Increased risk of pertussis in adult patients with mannose-binding lectin deficiency

Kirsi Gröndahl-Yli-Hannuksela1, Markku Viander, Jussi Mertsola

  • 1Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Turku, Finland.

Insights

Low mannose-binding lectin (MBL) levels increase susceptibility to infections. This study found MBL deficiency more common in pertussis patients, suggesting it predisposes adults to this respiratory illness.

Area of Science:

  • Immunology
  • Infectious Diseases

Background:

  • Mannose-binding lectin (MBL) is a key component of innate immunity.
  • Low serum MBL levels are linked to higher susceptibility to respiratory infections.

Purpose of the Study:

  • To investigate the association between MBL levels and pertussis infection.
  • To determine if MBL deficiency is a risk factor for pertussis.

Main Methods:

  • Quantified MBL concentrations in sera from 125 Finnish pertussis patients and 430 controls.
  • Compared the prevalence of severe MBL deficiency (<50 ng/mL) between patient and control groups.

Main Results:

  • Severe MBL deficiency was significantly more prevalent in pertussis patients (11.2%) than controls (5.8%, p=0.038).
  • MBL deficiency was notably higher in adult pertussis patients (20.4%) compared to adult controls (8.6%, p=0.021).
  • MBL deficiency showed an odds ratio of 2.7 for pertussis in adults.

Conclusions:

  • MBL deficiency appears to be a predisposing factor for pertussis infection, particularly in adults.
  • This study provides novel evidence linking MBL deficiency to pertussis susceptibility.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...